NCT03432650

Brief Summary

Hip arthroscopy is performed frequently and the postoperative course often involves moderate to severe pain. There remains no definitive perioperative pain regimen that has been proven to be effective and safe for this ambulatory procedure. Some institutions perform peripheral nerve blocks either preoperatively or postoperatively as a rescue block. All of these PNBs lead to quadriceps weakness which may impede earlier mobilization and physical therapy. While some case reports exist, there have not been any studies evaluating the QLB for hip arthroscopy patients. As previously mentioned, the technique is easy to perform, well-tolerated by patients, and avoids side effects such as hypotension, urinary retention, or the quadriceps weakness associated with lumbar plexus blockade.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
96

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Jun 2018

Typical duration for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 25, 2018

Completed
20 days until next milestone

First Posted

Study publicly available on registry

February 14, 2018

Completed
4 months until next milestone

Study Start

First participant enrolled

June 1, 2018

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2020

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 9, 2021

Completed
11 months until next milestone

Results Posted

Study results publicly available

August 19, 2022

Completed
Last Updated

August 19, 2022

Status Verified

July 1, 2022

Enrollment Period

2.6 years

First QC Date

January 25, 2018

Results QC Date

April 8, 2022

Last Update Submit

July 26, 2022

Conditions

Outcome Measures

Primary Outcomes (5)

  • Numerical Pain Rating System (NRS) Pain Scores

    Pain scores at rest and with movement will be through 24 hours after surgery. Score scale is from 0-10. 0 means no pain, 10 means worst pain. A lower score is a better outcome.

    30min after Post Anesthesia Care Unite (PACU) arrival

  • Numerical Pain Rating System (NRS) Pain Scores

    Pain scores at rest and with movement will be through 24 hours after surgery. Score scale is from 0-10. 0 means no pain, 10 means worst pain. A lower score is a better outcome.

    1 hour after Post Anesthesia Care Unite (PACU) arrival

  • Numerical Pain Rating System (NRS) Pain Scores

    Pain scores at rest and with movement will be through 24 hours after surgery. Score scale is from 0-10. 0 means no pain, 10 means worst pain. A lower score is a better outcome.

    2 hours after Post Anesthesia Care Unite (PACU) arrival

  • Numerical Pain Rating System (NRS) Pain Scores

    Pain scores at rest and with movement will be through 24 hours after surgery. Score scale is from 0-10. 0 means no pain, 10 means worst pain. A lower score is a better outcome.

    3 hours after Post Anesthesia Care Unite (PACU) arrival

  • Numerical Pain Rating System (NRS) Pain Scores

    Pain scores at rest and with movement will be through 24 hours after surgery. Score scale is from 0-10. 0 means no pain, 10 means worst pain. A lower score is a better outcome.

    24 hours after Post Anesthesia Care Unite (PACU) arrival

Secondary Outcomes (10)

  • Opioid Use

    After Surgery to Post Operative Day 1

  • Number of Patients With Presence of IAFE (Intraabdominal Fluid Extravasation) Following Surgery

    Immediately post-op in OR

  • Number of Patients With Nausea/Vomiting

    Up to Post Op Day 1

  • Antiemetic Use

    Up to Post Op Day 1

  • Number of Participants With Hospital Admission

    Up to Post Op Day 1

  • +5 more secondary outcomes

Study Arms (2)

QLB Block + Standard of Care

EXPERIMENTAL

Patients will receive either a spinal (4cc Mepivacaine) or combined spinal epidural anesthetic (dose up 50 5 cc 2% lidocaine) with IV sedation. Intraoperative anti-emetics will consist of IV ondansetron and IV dexamethasone. Intra-operative analgesics will be IV fentanyl, IV acetaminophen, IV ketorolac, and IV ketamine. No Block will be given. Patients will receive a single shot anterior QLB (30cc 0.5% Bupivacaine with 2mg preservative free dexamethasone).

Drug: Bupivacaine + dexamethasoneDevice: Ultrasound

Standard of Care

NO INTERVENTION

Patients will receive either a spinal (4cc Mepivacaine) or combined spinal epidural anesthetic (dose up 50 5 cc 2% lidocaine) with IV sedation. Intraoperative anti-emetics will consist of IV ondansetron and IV dexamethasone. Intra-operative analgesics will be IV fentanyl, IV acetaminophen, IV ketorolac, and IV ketamine. No Block will be given.

Interventions

Anesthetic that will help treat pain and sensation after hip arthroscopy

QLB Block + Standard of Care

Ultrasound will help guide the anesthesiologist in performing the nerve block

QLB Block + Standard of Care

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients scheduled for hip arthroscopy
  • Ability to follow study protocol
  • English Speaking

You may not qualify if:

  • Hepatic or renal insufficiency
  • Younger than 18 years old and older than 80
  • Allergy or intolerance to one of the study medications
  • Chronic gabapentin/pregabalin use (regular use for longer than 3 months)
  • Chronic opioid use (daily opioids use for longer than 3 months)
  • Patients contraindicated to undergo a spinal anesthetic
  • Non English Speakers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital of Special Surgery

New York, New York, 10021, United States

Location

MeSH Terms

Interventions

BupivacaineDexamethasoneUltrasonography

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesPregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, FluorinatedDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Results Point of Contact

Title
Dr. Stephen Haskins
Organization
Hospital for Special Surgery, Anesthesiology

Study Officials

  • Stephen Haskins, MD

    Hospital for Special Surgery, New York

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 25, 2018

First Posted

February 14, 2018

Study Start

June 1, 2018

Primary Completion

December 20, 2020

Study Completion

September 9, 2021

Last Updated

August 19, 2022

Results First Posted

August 19, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations